News
NHS England strikes deal on new NICE recommended lung cancer immunotherapy drug
NHS chief Simon Stevens has today announced that NHS England has struck a deal with MSD, endorsed by NICE, to make the lung cancer drug pembrolizumab available for routine use on the NHS. New trial results show pembrolizumab extends life for certain adults with lung cancer for more than a year. Pembrolizumab is the first […]
Hospital halves cardiac arrests as NHS uses smarter technology to save lives and improve care
Lives are being saved through the NHS’s use of smarter technology, including the introduction of a ‘game changing’ cancer treatment which reprogrammes patients’ own immune cells, NHS England Chief Executive Simon Stevens will announce today. In the NHS’s 70th year, the NHS is using smarter technology to halve the number of cardiac arrests, treat Sepsis […]
New ‘one stop shops’ for cancer to speed up diagnosis and save lives
New ‘one stop shops’ designed to speed-up cancer diagnosis and help save lives are being rolled out across the country. Rapid diagnostic and assessment centres are being piloted in ten areas as part of NHS England’s drive to catch cancer early and speed up diagnosis for people with cancer. Each of the centres will operate […]
NHS ‘one stop shop’ for prostate cancer means faster and more accurate diagnosis
The NHS is using cutting edge technology to help slash diagnosis times for prostate cancer from six weeks to one day in a world-leading new approach that virtually eliminates the risk of deadly sepsis. The new scanning and diagnosis method means a ‘one-stop-shop’ for suspected prostate cancer, the most common cancer in men in the […]
New Cancer Drugs Fund benefiting thousands of patients and releasing £140million for the NHS
Thousands of cancer patients have benefited from speedy access to the new and innovative treatments due to new Cancer Drugs Fund (CDF), which is also expected to release at least £140million into the NHS over the next five years. Since the new CDF opened in July 2016, nearly 15,700 patients have benefited from the 52 drugs […]
NHS cancer care has never been better with over two thousand more people surviving cancer every year
Thanks to improved NHS cancer care, over two thousand more people are this year able to enjoy Christmas with their families. Survival rates have never been higher and the gap between the best and the worst areas is also closing. Areas with historically lower survival rates are closing or have caught up with average survival, […]
NHS England action to save lives by catching more cancers early
NHS England Chief Executive, Simon Stevens, will today announce the scaling up of an innovative scheme that catches lung cancer early by scanning patients, along with new details of a more sensitive bowel cancer test that could save thousands of lives. Speaking at the Economist War on Cancer event in London, he will highlight the […]
NHS England announces plans to break down barriers for research
NHS England has today announced plans to accelerate the NHS’ national research strategy, cutting bureaucracy and speeding up access to new and innovative treatments. Speaking at the Economist War on Cancer event today, NHS Chief Executive Simon Stevens will tell delegates that the NHS is already one of the best places in the world to […]
Black and ethnic minority cancer patients encouraged to give feedback on their NHS care
NHS England Chief Executive Simon Stevens today issued an appeal for more black and ethnic minority (BME) patients to help improve cancer care by sharing their experiences. Speaking at the Economist’s War on Cancer event, Simon Stevens will point out that BME patients are less likely to give feedback about treatment, with only 50% of […]
NHS England strikes new deals to make two new innovative treatments available routinely on the NHS
NHS chief Simon Stevens will today announce that NHS England has struck deals to make innovative treatments for Multiple Sclerosis and breast cancer routinely available on the NHS. From tomorrow (10 November) hundreds of patients with Multiple Sclerosis are set to benefit from a new treatment option, Mavenclad, following a deal with drug company Merck. […]